Mymee provides specialized care and support to help people with systemic autoimmune diseases and long COVID improve quality of life.
Mymee is a remote care and support services company for people struggling with incurable rheumatic and neurological autoimmune diseases. Mymee programs combine expert health coaching, trigger identification and personalized care plans to reduce disease flares based on each individual's unique diet, lifestyle and environmental triggers. Results with Mymee in a randomly controlled trial demonstrated clinically significant improvements in 9 out of 10 health-related quality of life domains, including fatigue and pain among others.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 1, 2017 | Seed | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
AJI Capital | — | Seed |